Literature DB >> 3489941

Immune responses to H-2Kd antigen expressed by recombinant vaccinia virus.

B E Coupar, M E Andrew, D B Boyle, R V Blanden.   

Abstract

A recombinant vaccinia virus (VV-H2Kd-6) containing the coding sequence for the murine major histocompatibility complex class I antigen H-2Kd has been constructed and used to express H-2Kd on the surface of infected cells. Vaccinia expressed H-2Kd has been shown to generate an H-2Kd-specific primary cytotoxic T-cell response in mice infected with the recombinant virus and to stimulate an H-2Kd-specific cytotoxic T-cell response in vitro. Cells infected with the recombinant virus acted as targets for specific lysis by appropriate alloreactive cytotoxic T cells, albeit relatively inefficiently when compared with alloreactive recognition and specific lysis of H-2Kd-containing P815 cells. However, H-2Kd expressed by the recombinant virus was recognized efficiently as a restricting element in association with vaccinia virus antigens, while lysis of VV-H2Kd-6-infected L929 (H-2k) cells by CBA/H (H-2k) anti-C3H.OH (H-2KdDk) cytotoxic T cells was comparatively weak. These data suggest that there are quantitative or qualitative differences, or both, between H-2Kd expressed by vaccinia virus and cells of the H-2d haplotype. Qualitative differences have not been demonstrated but cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489941      PMCID: PMC386826          DOI: 10.1073/pnas.83.20.7879

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Estimates of the precursor frequency of cytotoxic T lymhocytes against antigens controlled by defined regions of the H-2 gene complex: comparison of the effect of H-2 differences due to intra-H-2 recombination vs mutation.

Authors:  M Pimsler; J Forman
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

2.  Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses.

Authors:  J E Ryser; H R MacDonald
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

3.  Neonatal tolerance to alloantigens alters major histocompatibility complex-restricted response patterns.

Authors:  A Müllbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

Review 4.  Quantitation and cloning of cytolytic T lymphocytes and their precursors.

Authors:  H R MacDonald; J C Cerottini; J E Ryser; J L Maryanski; C Taswell; M B Widmer; K T Brunner
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

5.  Cytotoxic T-memory cells in virus infection and the specificity of helper T cells.

Authors:  B A Askonas; A Mullbacher; R B Ashman
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

6.  In vitro primary induction of cytotoxic T cells against virus-infected syngeneic cells.

Authors:  R V Blanden; U Kees; M B Dunlop
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

7.  Inhibition of HeLa cell protein synthesis by the vaccinia virion.

Authors:  B Moss
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

8.  Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Authors:  D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.

Authors:  D B Boyle; B E Coupar; G W Both
Journal:  Gene       Date:  1985       Impact factor: 3.688

10.  An estimation of the frequency of precursor cells which generate cytotoxic lymphocytes.

Authors:  M A Skinner; J Marbrook
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Use of vaccinia virus to express biopharmaceutical products.

Authors:  D E Hruby; G Thomas
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

Review 2.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

3.  Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.

Authors:  M Lobigs; A Müllbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

5.  Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen.

Authors:  B Arnold; M Messerle; L Jatsch; G Küblbeck; U Koszinowski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Identification of human cancers deficient in antigen processing.

Authors:  N P Restifo; F Esquivel; Y Kawakami; J W Yewdell; J J Mulé; S A Rosenberg; J R Bennink
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

7.  Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation.

Authors:  J H Cox; J R Bennink; J W Yewdell
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo.

Authors:  R A Pereira; D C Tscharke; A Simmons
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.